The reason to stop infliximab is clearly related to the existence of new alternatives: a correspondence analysis of biologics, reasons to stop, and time periods

by Uceda, Julia, Carmona, Loreto, Muñoz, Alejandro, Marenco, Jose L
Published 2012

Changes in nailfold videocapillaroscopy in patients with granulomatosis with polyangiitis (Wegener’s): an observational study

by Uceda, Julia, Martinez, Rosalía, Velloso, María L, Marenco, José L
Published 2012

Wegener granulomatosis: type of presentation and initial treatment in a series of 23 cases

by Martínez-Pérez, Rosalia, Leon, Mario, Uceda, Julia, Montero, S Rodriguez, Muñoz, A, Velloso, ML, Marenco, JL
Published 2012

Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis

by Martínez-Pérez, Rosalía, Rodríguez-Montero, Sergio, Muñoz, Alejandro, Uceda, Julia, León, Mario, Gallo, Francisco, Velloso, Maria Luisa, Marenco, José Luis
Published 2011

Clinical and functional effectiveness of anti-TNF therapy in patients with rheumatoid arthritis

by Martínez-Pérez, Rosalia, Uceda, Julia, León, Mario, Rodríguez, Sergio, Muñoz, Alejandro, Gallo, Francisco, Velloso, Maria Luisa, Marenco, Jose Luis
Published 2011

Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis

by Martínez-Pérez, Rosalía, Rodríguez-Montero, Sergio, Muñoz, Alejandro, Uceda, Julia, León, Mario, Gallo, Francisco, Velloso, Maria Luisa, Marenco, José Luis
Published 2012